Iris Löw-Friedrich
Directeur Général chez ZOGENIX, INC.
Postes actifs de Iris Löw-Friedrich
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| UCB | Directeur Technique/Scientifique/R&D | 01/03/2008 | - |
| EVOTEC SE | Independent Dir/Board Member | 17/06/2014 | - |
| Président | 15/06/2021 | - | |
| Directeur/Membre du Conseil | 17/06/2014 | 15/06/2021 | |
| FRESENIUS SE & CO. KGAA | Directeur/Membre du Conseil | 13/05/2016 | - |
| Independent Dir/Board Member | 13/05/2016 | - | |
| ZOGENIX, INC. | President | - | - |
| Directeur Général | - | - | |
| Directeur/Membre du Conseil | 07/03/2022 | - | |
| Johann Wolfgang Goethe-Universität Frankfurt am Main | Corporate Officer/Principal | 01/01/2000 | - |
PhRMA Foundation
 PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services The PhRMA Foundation is an organization that provides awards and support to individuals pursuing higher education. The non-profit company is based in Washington. The organization's 2022 annual report highlights their activities and showcases their 2022 awardees. | Directeur/Membre du Conseil | 01/04/2019 | - |
Historique de carrière de Iris Löw-Friedrich
Anciens postes connus de Iris Löw-Friedrich
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Directeur/Membre du Conseil | 01/04/2014 | 01/09/2015 |
| Président | 01/09/2015 | 01/09/2017 | |
UCB Pharma GmbH
 UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Directeur Technique/Scientifique/R&D | 01/08/2001 | 01/01/2009 |
| BASF SE | Corporate Officer/Principal | 01/01/2000 | 01/01/2001 |
| ░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
| ░░░░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Formation de Iris Löw-Friedrich
| Johann Wolfgang Goethe-Universität Frankfurt am Main | Doctorate Degree |
Statistiques
Internationale
| Allemagne | 10 |
| Etats-Unis | 5 |
| Belgique | 2 |
Opérationnelle
| Director/Board Member | 6 |
| Corporate Officer/Principal | 5 |
| Chief Tech/Sci/R&D Officer | 4 |
Sectorielle
| Health Technology | 8 |
| Consumer Services | 3 |
| Process Industries | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| FRESENIUS SE & CO. KGAA | Health Technology |
| BASF SE | Producer Manufacturing |
| UCB | Health Technology |
| EVOTEC SE | Health Technology |
| HEIDELBERG PHARMA AG | Health Technology |
| Entreprise privées | 8 |
|---|---|
Hoechst AG
 Hoechst AG Chemicals: Major DiversifiedProcess Industries Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany. | Process Industries |
UCB Pharma GmbH
UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Health Technology |
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
| Aventis Pharma AG | |
| Hoechst Marion Roussel, Inc. | |
| BASF Pharma | |
PhRMA Foundation
PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services The PhRMA Foundation is an organization that provides awards and support to individuals pursuing higher education. The non-profit company is based in Washington. The organization's 2022 annual report highlights their activities and showcases their 2022 awardees. | Commercial Services |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Health Technology |
- Bourse
- Insiders
- Iris Löw-Friedrich
- Expérience
